Dual PPAR-α and -γ activators derived from novel benzoxazinone containing thiazolidinediones having antidiabetic and hypolipidemic potential
Authors:
- Gurram R. MadhavanGMGurram R. Madhavan
- Ranjan ChakrabartiRCRanjan Chakrabarti
- K. Anantha ReddyKRK. Anantha Reddy
- B.M. RajeshBRB.M. Rajesh
- V. BalrajuVBV. Balraju
- P. Bheema RaoPRP. Bheema Rao
- R. RajagopalanRRR. Rajagopalan
- Javed IqbalJIJaved Iqbal
- 1 January 2006
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 14 (2) , 584-591
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γJournal of Clinical Investigation, 2004
- Design and Synthesis of Subtype- and Species-Selective Peroxisome Proliferator-Activated Receptor (PPAR) Alpha LigandsYAKUGAKU ZASSHI, 2004
- Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 DiabetesJournal of Medicinal Chemistry, 2004
- Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivativesBioorganic & Medicinal Chemistry, 2002
- Mechanism of Action of Fibrates on Lipid and Lipoprotein MetabolismCirculation, 1998
- Insulin-sensitising agentsExpert Opinion on Emerging Drugs, 1998
- Role of PPAR in the Pharmacological Regulation of Lipoprotein Metabolism by Fibrates and ThiazolidinedionesCurrent Pharmaceutical Design, 1997
- New Antianginal Nitro Esters with Reduced Hypotensive Activity. Synthesis and Pharmacological Evaluation of 3-[(Nitrooxy)alkyl]-2H-1,3-benzoxazin-4(3H)-onesJournal of Medicinal Chemistry, 1995
- Synthesis of 2-phenylthiazolidine derivatives as cardiotonic agents. II. 2-(Phenylpiperazinoalkoxyphenyl)thiazolidine-3-thiocarboxamides and the corresponding carboxamides.Chemical and Pharmaceutical Bulletin, 1987
- Insulin Resistance in Genetically Obese, Hyperglycemic MiceEndocrinology, 1971